Biote to Participate at Upcoming Investor Conferences
May 31 2023 - 7:30AM
Business Wire
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a
leading solutions provider in preventive health care through the
delivery of personalized hormone therapy, today announced its
participation at the following investor conferences:
- On June 6, 2023, Terry Weber, Biote’s Chief Executive Officer,
and Samar Kamdar, Biote’s Chief Financial Officer, will present at
10:40 AM ET at TD Cowen’s 7th Annual Future of the Consumer
Conference in New York, NY. Marc Beer, Biote’s Executive Chairman,
will join Ms. Weber and Mr. Kamdar in hosting investor meetings at
the conference.
- On June 8, 2023, Ms. Weber and Mr. Kamdar will present at 2:00
PM ET at the Jefferies Healthcare Conference in New York, NY. Mr.
Beer will join Ms. Weber and Mr. Kamdar in hosting investor
meetings at the conference. A live webcast of the presentation will
be available on Biote’s Investor Relations website here. The
webcast replay will be available for 90 days following the live
event on Biote’s Investor Relations website here.
About Biote
Biote is transforming healthy aging through innovative,
personalized hormone optimization therapies delivered by
Biote-certified medical providers. Biote trains practitioners how
to identify and treat early indicators of hormone-related aging
conditions, an underserved $7 billion global market, providing
affordable symptom relief for patients and driving clinic success
for practitioners.
Forward-Looking Statements
This press release contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Some of the forward-looking statements can be identified
by the use of forward-looking words. Statements that are not
historical in nature, including the words “may,” “can,” “should,”
“will,” “estimate,” “plan,” “project,” “forecast,” “intend,”
“expect,” “hope,” “anticipate,” “believe,” “seek,” “target,”
“continue,” “could,” “might,” “ongoing,” “potential,” “predict,”
“would” and other similar expressions, are intended to identify
forward-looking statements. Forward-looking statements are
predictions, projections and other statements about future events
that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Many factors could
cause actual results or developments to differ materially from
those expressed or implied by such forward-looking statements,
including but not limited to: the success of our dietary
supplements to attain significant market acceptance among clinics,
practitioners and their patients; our customers’ reliance on
certain third parties to support the manufacturing of bio-identical
hormones for prescribers; our and our customers’ sensitivity to
regulatory, economic, environmental and competitive conditions in
certain geographic regions; our ability to increase the use by
practitioners and clinics of the Biote Method at the rate that we
anticipate or at all; our ability to grow our business; the
significant competition we face in our industry; our limited
operating history; our ability to protect our intellectual
property; the heavy regulatory oversight in our industry; changes
in applicable laws or regulations; the inability to profitably
expand in existing markets and into new markets; the possibility
that we may be adversely impacted by other economic, business
and/or competitive factors, including recent bank failures; and
future exchange and interest rates. The foregoing list of factors
is not exhaustive. You should carefully consider the foregoing
factors and the other risks and uncertainties described in the
“Risk Factors” section of Biote’s Quarterly Report on Form 10-Q for
the fiscal quarter ended March 31, 2023 and other documents filed
by Biote from time to time with the Securities and Exchange
Commission. These filings identify and address other important
risks and uncertainties that could cause actual events and results
to differ materially from those contained in the forward-looking
statements. Forward-looking statements speak only as of the date
they are made. Readers are cautioned not to put undue reliance on
forward-looking statements, and Biote assumes no obligation and
does not intend to update or revise these forward-looking
statements, whether as a result of new information, future events,
or otherwise. Biote does not give any assurance that it will
achieve its expectations.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230531005097/en/
Media Contact Press@biote.com
Investor Contact IR@biote.com
Biote (NASDAQ:BTMD)
Historical Stock Chart
From Apr 2024 to May 2024
Biote (NASDAQ:BTMD)
Historical Stock Chart
From May 2023 to May 2024